Ex Parte MacPherson et alDownload PDFPatent Trial and Appeal BoardFeb 18, 201611832439 (P.T.A.B. Feb. 18, 2016) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 111832,439 08/01/2007 64091 7590 02/22/2016 AFTON CHEMICAL CORPORATION LUEDEKA NEELY GROUP P.O. BOX 1871 KNOXVILLE, TN 37901 FIRST NAMED INVENTOR Ian MacPherson UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. 63094.US (AC-7842) 6086 EXAMINER PO, MING CHEUNG ART UNIT PAPER NUMBER 1771 NOTIFICATION DATE DELIVERY MODE 02/22/2016 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address( es): LNG.PA TENT@gmail.com docketing@luedeka.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte IAN MACPHERSON, JOSEPH W. ROOS, and THOMAS G. QUINN Appeal2014-006780 Application 11/832,439 Technology Center 1700 Before BEYERL YA. FRANKLIN, KAREN M. HASTINGS, and WESLEY B. DERRICK, Administrative Patent Judges. HASTINGS, Administrative Patent Judge. DECISION ON APPEAL Appellants 1 seek our review under 35 U.S.C. § 134(a) of a decision of the Primary Examiner to reject claim 1--4, 9-23, 31, 32, 35 and 37--46 under 35 U.S.C. § 103(a) based on at least Chiu (US 2003/0186824 Al, pub. October 2, 2003).2' 3 We have jurisdiction under 35 U.S.C. § 6(b). 1 The Real Party in Interest is stated to be Afton Chemical Corporation (Br. 2). 2 The Examiner applied additional prior art to dependent claims 9, and 14-- 19 (Final Act. 7-10). Appellants do not rely upon any additional arguments for these claims (Br. generally). 3 Appellants do not appeal the rejection of claim 6 as the claim was cancelled in an amendment after final dated May 29, 2013. Appeal2014-006780 Application 11/832,439 The Examiner's provisional obviousness-type double patenting rejections (Final Rej. 3, 4; Ans. 2, 3) are summarily affirmed as Appellants do not provide any argument directed towards these rejections (Br. 4, 11 ). The Examiner also inadvertently omitted claims 33 and 34 from the final rejection (Br. 16). While the Final Rejection cover sheet indicated these claims were rejected (and thus their omission may be considered harmless error), the Examiner nonetheless made a new ground of rejection in the Examiner's Answer to explicitly include these claims (Ans. 9). Appellants have not filed a responsive reply brief. Accordingly, these claims are dismissed; see 37 CPR§ 41.39(b) and MPEP § 1207.03. Representative claim 1 is directed to "[a]n environmentally compatible fuel additive composition" (Claims App). Independent claim 3 1 is directed to a "method of making an environmentally compatible fuel composition" that includes "a minor amount" of an additive composition corresponding to claim 1, and independent claim 37 is directed to an "environmentally compatible fuel composition" that includes "a minor amount" of an additive composition corresponding to claim 1 (Id.). ANALYSIS Upon consideration of the appeal record, including the Appellants' position in this appeal as set forth on pages 12-16 of the Appeal Brief, we affirm the Examiner's rejections for the reasons stated by the Examiner (Final Act. 2-12; Ans. 3-12). It has been established that "the [obviousness] analysis need not seek out precise teachings directed to the specific subject matter of the challenged 2 Appeal2014-006780 Application 11/832,439 claim, for a court can take account of the inferences and creative steps that a person of ordinary skill in the art would employ." KSR Int'! Co. v. Teleflex Inc., 550 U.S. 398, 418 (2007); see also In re Fritch, 972 F.2d 1260, 1264-- 65 (Fed. Cir. 1992) (a reference stands for all of the specific teachings thereof as well as the inferences one of ordinary skill in the art would have reasonably been expected to draw therefrom). Notably, Appellants have not presented any cogent arguments sufficient to address the Examiner's obviousness position. Appellants merely assert, contrary to the record, that the Examiner "failed to consider" that these claims are directed to a fuel composition (Br. 12). First, many of the claims, e.g., claim 1, 2, etc., are directed to an additive composition, not a fuel composition per se (Ans. 10). As such the composition of Chiu merely needs to be capable of use as a fuel additive. Appellants have offered no persuasive technical reasoning or proof that the composition of Chiu is incapable of being used as a fuel additive. Indeed, the Examiner's finding that lubricants, such as those taught in Chiu, are known to be used as fuel additives (Id.) stands unrebutted on this record (Br. 12-15). Accordingly, Appellants have not shown error in the Examiner's determination that one of ordinary skill in the art, using no more than ordinary creativity, would have used an environmentally friendly lubricant composition as exemplified by Chiu as an additive to a known fuel composition (e.g., Ans. 3-5; Br., generally,). KSR, 550 U.S. at 417 (The predictable use of prior art elements or steps according to known methods for their established functions is likely to be obvious when it does no more than yield predictable results). "A person of ordinary skill is also a person of ordinary creativity, not an automaton." Id. at 421. 3 Appeal2014-006780 Application 11/832,439 Appellants' additional arguments are adequately addressed by the Examiner (Ans. 10 and 11). In summary, the appeal is dismissed as to claims 33 and 34, and all of the Examiner's remaining § 103 rejections are affirmed. The Examiner's provisional obviousness-type double patenting rejections are summarily affirmed. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a)(l). AFFIRMED KRH 4 k Copy with citationCopy as parenthetical citation